cholesterol drugs come with a higher rate of suicide
In more than one way,....does cholesterol metabolism still take up the bottom fifth of Boehringer Mannheim's biochemical pathways chart?,..is it still Boehringer Mannheim? All those interesting hormones. And then there is cholesterol's effects on fluidity and permeability of cell membranes,...should be able to really kick up a storm both chemically and electrically in the brain.
Personally I think Pennsaid should be approved right now, but I'm an investor, not worried about legal responsibility. I fully agree that I would prefer a little rash on the application site instead of taking pills that may rot my guts. Obvious decision for me.
But then I also know that the average person out there who has pain in a joint knows little about medicine, biology etc. They have a pain and go to doctors to accept whatever relief they prescribe. If the treatment is messy, hard to use, causes a rash, takes too much time and trouble to apply, needs a clean application area (can't tell you how many people I see leave public washrooms in food courts without washing their hands only to sit down and eat), is too hard or bulky to carry,...etc., etc., back to the doctor they go and get the pill. If everyone was smart and aware, who would smoke, drink excessively, live in the city, eat fatty foods, eat most prepared foods in the supermarket, put their fingers in their mouth and or pick their nose (gggggggggg), eat food in restaurants if you ever worked in the kitchen of one (gggggggg), drink most water, etc., etc.
When assessing those probabilities of quickness of adoption and potential revenues, perhaps we should assess some bigger negatives to the implications of some of the above things customer centric variables.
No doubt each milestone will cause jumps in the shareprice, but they will only last if the revenues and cashflow build significantly quarter to quarter.
Does anyone know why the "PENNSAID® Open Investigational New Drug (IND) Study" rate of increase of new active patients seemed to trail off so much in the last two years? One would have expected word of mouth and physician support to continually build the rate of increase at a steady rate if patients enjoyed and recommended the treatment to their friends.
Edit: Just found something you may be interested here on Psoriasis
http://www.dermnet.com/project2/NewFiles/krugerlect.html |
